Maintenance of PtdIns45P2 pools under limiting inositol conditions, as assessed by liquid chromatography-tandem mass spectrometry and PtdIns45P2 mass evaluation in Ras-transformed cells

European Journal of Cancer

Volumn 38, Issue 18, 2002, Pages 2463-2475

  Berrie, C P ^a   Dragani, L K ^b   Van der Kaay, J ^c   Iurisci, C ^a   Brancaccio, A ^a,d   Rotilio, D ^b   Corda, D ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b G Paone Environmental Health Center   (Italy)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

Glycerophosphoinositol; Inositol phosphates; Liquid chromatography tandem mass spectrometry; Phosphatidylinositol 4,5 bisphosphate; Phosphoinositides; Ras transformation

Indexed keywords

ADENYLATE CYCLASE; CELL EXTRACT; GLYCEROPHOSPHORYLINOSITOL; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL DERIVATIVE; LYSOPHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE A2; POLYPHOSPHOINOSITIDE; RAS PROTEIN; TRITIUM; UNCLASSIFIED DRUG; GLYCERYLPHOSPHOINOSITOL; INOSITOL; INOSITOL PHOSPHATE; LYSOPHOSPHOLIPID;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CARCINOMA CELL; CELL LEVEL; CELL PROLIFERATION; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; CELL CULTURE; CHEMISTRY; GENETICS; HUMAN; INTRACELLULAR FLUID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; ONCOGENE RAS; PHYSIOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, LIQUID; GENES, RAS; HUMANS; INOSITOL; INOSITOL PHOSPHATES; INTRACELLULAR FLUID; LYSOPHOSPHOLIPIDS; MASS SPECTROMETRY; TUMOR CELLS, CULTURED;

EID: 0036893523     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00485-9     Document Type: Article

References (38)

1. Irvine R.F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem. J. 204:1982;3-16.
2. Piomelli D. Arachidonic acid in cell signalling. Curr Opin Cell Biol. 5:1993;274-280.
3. 2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells. Cell Signal. 3:1991;321-332.
4. Falasca M., Corda D. Elevated levels and mitogenic activity of lysophosphatidylinositol in K-Ras-transformed epithelial cells. Eur J Biochem. 221:1994;383-389.
5. Falasca M., Silletta M.G., Carvelli A.et al. Signalling pathways involved in the mitogenic action of lysophosphatidylinositol. Oncogene. 10:1995;2113-2124.
6. Falasca M., Iurisci C., Carvelli A., Sacchetti A., Corda D. Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation. Oncogene. 16:1998;2357-2365.
7. Alonso T., Morgan R.O., Marvizon J.C., Zarbl H., Santos E. Malignant transformation by Ras and other oncogenes produces common alterations in inositol phospholipid signalling pathways. Proc Natl Acad Sci USA. 85:1988;4271-4275.
8. Alonso T., Santos E. Increased intracellular glycerophosphoinositol as a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes. Biochem. Biophys. Res. Commun. 171:1990;14-19.
9. Corda D., Falasca M. Glycerophosphoinositols as potential markers of Ras-induced transformation and novel second messengers. Anticancer Res. 16:1996;1341-1350.
10. Falasca M., Marino M., Carvelli A., Iurisci C., Leoni S., Corda D. Changes in the levels of glycerophosphoinositols during differentiation of hepatic and neuronal cells. Eur J Biochem. 241:1996;386-392.
11. French P.J., Bunce C.M., Stephens L.R.et al. Changes in the levels of inositol lipids and phosphates during the differentiation of HL-60 promyelocytic cells towards neutrophils or monocytes. Proc R Soc Lond B. 245:1991;193-201.
12. Bunce C.M., French P.J., Patton W.N.et al. Levels of inositol metabolites within normal myeloid blast cells and changes during their differentiation towards monocytes. Proc R Soc Lond B. 247:1992;27-33.
13. Mountford J.D., Bunce C.M., French P.J., Michell R.H., Brown G. Intracellular concentrations of inositol, glycerophosphoinositol and inositol pentakisphosphate increase during haematopoietic cell differentiation. Biochim Biophys Acta. 1222:1994;101-108.
14. Corda D., Iurisci C., Berrie C.P. Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols. Biochim Biophys Acta. 1582:2002;52-69.
15. 3 in unstimulated and vasopressin-stimulated rat hepatocytes. Cell Signal. 1:1989;147-156.
16. Bunce C.M., French P.J., Allen P.et al. Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts. Biochem. J. 289:1993;667-673.
17. Chilvers E.R., Batty I.H., Challiss R.A., Barnes P.J., Nahorski S.R. Determination of mass changes in phosphatidylinositol 4,5-bisphosphate and evidence for agonist-stimulated metabolism of inositol 1,4,5-trisphosphate in airway smooth muscle. Biochem. J. 275:1991;373-379.
18. 3 production in rat skeletal muscle in vivo. J Biol Chem. 272:1997;5477-5481.
19. Berrie C.P., Iurisci C., Corda D. Membrane transport and in vitro metabolism of the Ras cascade messenger, glycerophosphoinositol 4-phosphate. Eur J Biochem. 266:1999;413-419.
20. + as secondary, selective, consequences of inositol depletion in 1321N1 cells. Biochem. J. 297:1994;529-537.
21. Batty I.H., Michie A., Fennel M., Downes C.P. The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells. Biochem. J. 294:1993;49-55.
22. +. J Neurochem. 65:1995;2279-2289.
23. Speed C.J., Mitchell C.A. Sustained elevation in inositol 1,4,5-trisphosphate results in inhibition of phosphatidylinositol transfer protein activity and chronic depletion of the agonist-sensitive phosphoinositide pool. J Cell Sci. 113:2000;2631-2638.
24. Batty I.H., Currie R.A., Downes C.P. Evidence for a model of integrated inositol phospholipid pools implies an essential role for lipid transport in the maintenance of receptor-mediated phospholipase C activity in 1321N1 cells. Biochem. J. 330:1998;1069-1077.
25. Lykidis A., Jackson P.D., Rock C.O., Jackowski S. The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content. J Biol Chem. 272:1997;33402-33409.
26. Nahorski S.R., Ragan C.I., Challiss R.A.J. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci. 12:1991;297-303.
27. Huang M., Chida K., Kamata N.et al. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in Ras-transformed rat fibroblasts. J Biol Chem. 263:1988;17975-17980.
28. van der Kaay J., Draijer R., van Haastert P.J.M. Increased conversion of phosphatidylinositol to phosphatidylinositol phosphate in Dictyostelium cells expressing a mutated Ras gene. Proc Natl Acad Sci USA. 87:1990;9197-9201.
29. Lacal J.C. Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21Ras proteins is a consequence of activation of phosphatidylcholine metabolism. Mol Cell Biol. 10:1990;333-340.
30. Snoek G.T., Berrie C.P., Geijtenbeek T.B.et al. Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A. J Biol Chem. 274:1999;35393-35399.
31. Weiltzien H.U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta. 559:1979;259-287.
32. 31P NMR. J Biol Chem. 262:1987;35-37.
33. Ross T.S., Whiteley B., Graham R.A., Majerus P.W. Cyclic hydrolase-transfected 3T3 cells have low levels of inositol 1,2-cyclic phosphate and reach confluence at low density. J Biol Chem. 266:1991;9086-9092.
34. Ross T.S., Majerus P. Identification of a phosphodiesterase that converts inositol cyclic 1:2-phosphate to inositol 2-phosphate. J Biol Chem. 267:1992;19924-19928.
35. Sekar M.C., Sambandam V., Roy D., Grizzle W.E. Decreased cyclic inositol phosphohydrolase activity in hamster renal tumors and human renal cell carcinomas. Biochem Mol Med. 56:1995;104-107.
36. Xiao Y., Chen Y., Kennedy A.W., Belinson J., Xu Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann NY Acad Sci. 905:2000;242-259.
37. Xiao Y.J., Schwartz B., Washington M.et al. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem. 290:2001;302-313.
38. Xu Y., Xiao Y.J., Baudhuin L.M., Schwartz B.M. The role and clinical applications of bioactive lysolipids in ovarian cancer. J Soc Gynecol Investig. 8:2001;1-13.